. Get the latest %COMPANY_NAME% TORC detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Forward-looking statements are neither historical facts nor assurances of future performance. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Don’t Retire If You’re Relying ONLY on the OAS and CPP Pension “We believe that our allogeneic gamma delta T cell approach may provide a unique treatment paradigm by combining the innate anti-tumor response, consistent with natural killer cells, and adaptive anti-tumor response consistent with other populations of T cells, such as alpha-beta T cells. The use of words such as, but not limited to, “believe,” “expect,” “estimate,” “project,” “intend,” “future,” “potential,” “continue,” “may,” “might,” “plan,” “will,” “should,” “seek,” “anticipate,” or “could” and other similar words or expressions are intended to identify forward-looking statements. (TORC) raised $86 million in an initial public offering (IPO) on Friday, January 26th 2018.
Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. To see all exchange delays and terms of use please see disclaimer. Currency in CAD. New risks and uncertainties may emerge from time to time, and it is not possible to predict all risks and uncertainties. An all-star lineup of business leaders tell us what to expect amid generational change. Post-merger and post-reverse split, Adicet has approximately 19,589,828 million shares of common stock issued and outstanding with prior Adicet equityholders collectively owning approximately 75% of the combined company on a fully-diluted basis, and prior resTORbio equityholders collectively owning approximately 25% of the combined company on a fully-diluted basis (in each case excluding equity incentives available for grant). 6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for resTORbio in the last year. This suggests a possible upside of 88.0% from the stock's current price. The new combined company will operate under the name Adicet Bio, Inc. and will commence trading on the Nasdaq Global Market under the ticker symbol “ACET” on September 16, 2020.Adicet will focus on advancing its pipeline of “off-the-shelf” gamma delta T cells, engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and improve persistence for durable activity in patients. \- Adicet Emerges as a Leading Allogeneic Gamma Delta T Cell Therapy Company Focused on Oncology - -Trading to Commence on September 16, 2020 on The Nasdaq Global Market Under Ticker Symbol “ACET”-MENLO PARK, Calif. and BOSTON, Sept. 15, 2020 (GLOBE NEWSWIRE) -- Adicet Bio, Inc., a biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases, today announced the completion of its previously announced merger with resTORbio, Inc. (previously trading on Nasdaq under the symbol “TORC”). This represents a $0.06 dividend on an annualized basis and a yield of 3.92%. Vote “Outperform” if you believe TOG will outperform the S&P 500 over the long term. 6 analysts have issued 1 year price targets for resTORbio's stock. MENLO PARK, Calif. and BOSTON, Sept. 22, 2020 (GLOBE NEWSWIRE) -- Adicet Bio, Inc. (Nasdaq: ACET), a biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases, announced today that it has determined not to proceed with its proposed public offering of 4,500,000 shares of its common stock previously announced on September 21, 2020. © 2020 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. Wall Street is in panic mode… they don’t know what to do…
Fundamental company data provided by Morningstar and Zacks Investment Research.
The company can be reached via phone at 403-930-4120. © American Consumer News, LLC dba MarketBeat® 2010-2020. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Do Not Sell My Information.
For more information, please visit our website at http://www.adicetbio.com.Forward-Looking Statements This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements regarding: future product development plans and projected timelines for the initiation and completion of preclinical and clinical trials and other activities; the potential for the results of ongoing preclinical or clinical trials and the efficacy of Adicet’s drug candidates; and future product development and regulatory strategies, including with respect to specific indications. TORC Oil and Gas does not have a long track record of dividend growth. Since then, TOG stock has increased by 26.0% and is now trading at C$1.65. Shares of TOG and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms and Conditions of Service. resTORbio does not have a long track record of dividend growth. and Mr. Schor, who join from resTORbio’s board of directors, and Steve Dubin, who joined the Board of Directors at the closing. (Add your “underperform” vote.). All information in this press release is as of the date of the release, and Adicet undertakes no duty to update this information unless required by law.Adicet Bio, Inc. Investor and Media Contacts Anne Bowdidge abowdidge@adicetbio.comJanhavi Mohite Stern Investor Relations, Inc. 212-362-1200 janhavi.mohite@sternir.com. CALGARY, AB, Oct. 1, 2020 /CNW/ - TORC Oil & Gas Ltd. Rex MD prescribes E.D. View analyst ratings for resTORbio. Only 11.80% of the stock of resTORbio is held by insiders. TORC Oil & Gas Ltd. engages in the exploration and production of petroleum and natural gas in the Western Canadian Sedimentary Basin. Real time prices by BATS.
One share of TOG stock can currently be purchased for approximately C$1.53. It focused on the development and commercialization of therapeutics for the treatment of aging-related diseases.
If you wish to go to ZacksTrade, click OK. TORC Oil and Gas has a P/B Ratio of 0.69. The Company believes that current market conditions are not conducive to an offering on terms that would be in the best interests of its current stockholders. Any forward-looking statements in this press release are based on management’s current expectations and beliefs of future events, and are subject to a number of risks and uncertainties that could cause actual results to differ materially and adversely from those set forth in or implied by such forward-looking statements.
The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank. The company earns $-82,740,000.00 in net income (profit) each year or ($2.41) on an earnings per share basis. Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab. These risks and uncertainties related to market conditions as well as risks and uncertainties inherent in Adicet’s business. The company's average rating score is 2.71, and is based on 5 buy ratings, 2 hold ratings, and no sell ratings. 7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for TORC Oil and Gas in the last year. Learn more. Updated every 15 seconds.
Boston Beer (NYSE: SAM) Pops on Earnings Again… Is it Still a Buy? Learn more. View TORC's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at MarketBeat. You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. TORC Oil and Gas pays a meaningful dividend of 3.75%, higher than the bottom 25% of all stocks that pay dividends. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. publicly available sources. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. © 2020 Verizon Media. Find the latest resTORbio, Inc. (TORC) stock quote, history, news and other vital information to help you with your stock trading and investing. We look forward to progressing multiple programs into the clinic, targeting both hematological and solid tumors.”Adicet anticipates the following near-term milestones: * File IND for ADI-001 CD20 gamma delta CAR-T * Phase 1 clinical study of ADI-001 in non-Hodgkin’s lymphoma * ADI-001 expansion in diffuse large B-cell lymphoma and/or mantle cell lymphoma * File IND for ADI-002 GPC3 gamma-delta CAR-T * Initiate Phase 1 clinical study in hepatocellular carcinoma and other solid tumorsIn connection with the closing of the merger, resTORbio effected a 7:1 reverse split of its common stock. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.